2021-05-13 |
2021-05-11 |
VP
Vente planifiée
|
Brockstedt Dirk G.
Chief Scientific Officer
Dirigeant
|
2 648
-11.8%
18,19
48 167
USD
|
2 648
-11.8%
|
18,19
|
48 167
USD
|
|
2021-05-05 |
2021-05-03 |
VP
Vente planifiée
|
HO WILLIAM
Chief Medical Officer
Dirigeant
|
1 000
-1.5%
22,04
22 040
USD
|
1 000
-1.5%
|
22,04
|
22 040
USD
|
|
2021-04-16 |
2021-04-15 |
VP
Vente planifiée
|
HO WILLIAM
Chief Medical Officer
Dirigeant
|
1 000
-1.6%
21,14
21 140
USD
|
1 000
-1.6%
|
21,14
|
21 140
USD
|
|
2021-04-14 |
2021-04-13 |
A
Achat
|
Robbins Wendye
Administrateur non-exécutif
|
300
+5.2%
19,40
5 820
USD
|
300
+5.2%
|
19,40
|
5 820
USD
|
|
2021-04-14 |
2021-04-13 |
A
Achat
|
Robbins Wendye
Administrateur non-exécutif
|
400
+7.4%
19,50
7 800
USD
|
400
+7.4%
|
19,50
|
7 800
USD
|
|
2021-04-01 |
2021-04-01 |
VP
Vente planifiée
|
HO WILLIAM
Chief Medical Officer
Dirigeant
|
1 000
-1.5%
22,66
22 660
USD
|
1 000
-1.5%
|
22,66
|
22 660
USD
|
|
2021-03-17 |
2021-03-15 |
VP
Vente planifiée
|
HO WILLIAM
Chief Medical Officer
Dirigeant
|
1 000
-1.5%
21,91
21 910
USD
|
1 000
-1.5%
|
21,91
|
21 910
USD
|
|
2021-03-02 |
2021-03-01 |
VP
Vente planifiée
|
HO WILLIAM
Chief Medical Officer
Dirigeant
|
1 000
-1.5%
18,60
18 600
USD
|
1 000
-1.5%
|
18,60
|
18 600
USD
|
|
2021-02-17 |
2021-02-16 |
VP
Vente planifiée
|
Brockstedt Dirk G.
Chief Scientific Officer
Dirigeant
|
9 877
-33.3%
21,22
209 590
USD
|
9 877
-33.3%
|
21,22
|
209 590
USD
|
|
2021-02-17 |
2021-02-16 |
VP
Vente planifiée
|
HO WILLIAM
Chief Medical Officer
Dirigeant
|
1 000
-1.5%
21,81
21 810
USD
|
1 000
-1.5%
|
21,81
|
21 810
USD
|
|
2021-02-02 |
2021-02-01 |
VP
Vente planifiée
|
HO WILLIAM
Chief Medical Officer
Dirigeant
|
1 000
-1.5%
19,99
19 990
USD
|
1 000
-1.5%
|
19,99
|
19 990
USD
|
|
2021-01-15 |
2021-01-15 |
VP
Vente planifiée
|
HO WILLIAM
Chief Medical Officer
Dirigeant
|
831
-1.2%
21,05
17 493
USD
|
831
-1.2%
|
21,05
|
17 493
USD
|
|
2021-01-15 |
2021-01-15 |
VP
Vente planifiée
|
HO WILLIAM
Chief Medical Officer
Dirigeant
|
169
-0.2%
21,05
3 557
USD
|
169
-0.2%
|
21,05
|
3 557
USD
|
|
2021-01-06 |
2021-01-06 |
VP
Vente planifiée
|
Brockstedt Dirk G.
Chief Scientific Officer
Dirigeant
|
1 179
-6.3%
19,68
23 203
USD
|
1 179
-6.3%
|
19,68
|
23 203
USD
|
|
2021-01-06 |
2021-01-05 |
V
Vente
|
Brockstedt Dirk G.
Chief Scientific Officer
Dirigeant
|
821
-4.2%
19,76
16 225
USD
|
821
-4.2%
|
19,76
|
16 225
USD
|
|
2021-01-04 |
2021-01-04 |
VP
Vente planifiée
|
HO WILLIAM
Chief Medical Officer
Dirigeant
|
775
-1.1%
19,75
15 306
USD
|
775
-1.1%
|
19,75
|
15 306
USD
|
|
2021-01-04 |
2021-01-04 |
VP
Vente planifiée
|
HO WILLIAM
Chief Medical Officer
Dirigeant
|
225
-0.3%
19,75
4 444
USD
|
225
-0.3%
|
19,75
|
4 444
USD
|
|
2020-12-15 |
2020-12-15 |
VP
Vente planifiée
|
HO WILLIAM
Chief Medical Officer
Dirigeant
|
795
-1.1%
24,55
19 517
USD
|
795
-1.1%
|
24,55
|
19 517
USD
|
|
2020-12-15 |
2020-12-15 |
VP
Vente planifiée
|
HO WILLIAM
Chief Medical Officer
Dirigeant
|
205
-0.3%
24,55
5 033
USD
|
205
-0.3%
|
24,55
|
5 033
USD
|
|
2020-12-01 |
2020-12-01 |
VP
Vente planifiée
|
HO WILLIAM
Chief Medical Officer
Dirigeant
|
524
-0.7%
21,83
11 439
USD
|
524
-0.7%
|
21,83
|
11 439
USD
|
|
2020-12-01 |
2020-12-01 |
VP
Vente planifiée
|
HO WILLIAM
Chief Medical Officer
Dirigeant
|
476
-0.7%
21,83
10 391
USD
|
476
-0.7%
|
21,83
|
10 391
USD
|
|
2020-11-23 |
2020-11-19 |
A
Achat
|
Robbins Wendye
Administrateur non-exécutif
|
500
+inf%
16,09
8 045
USD
|
500
+inf%
|
16,09
|
8 045
USD
|
|
2020-11-23 |
2020-11-19 |
A
Achat
|
Robbins Wendye
Administrateur non-exécutif
|
500
+10.9%
16,08
8 040
USD
|
500
+10.9%
|
16,08
|
8 040
USD
|
|
2020-11-20 |
2020-11-19 |
A
Achat
|
RIEFLIN WILLIAM JL
Administrateur non-exécutif
|
10 000
+125.0%
16,22
162 200
USD
|
10 000
+125.0%
|
16,22
|
162 200
USD
|
|
2020-11-18 |
2020-11-16 |
VP
Vente planifiée
|
HO WILLIAM
Chief Medical Officer
Dirigeant
|
1 000
-1.4%
20,25
20 250
USD
|
1 000
-1.4%
|
20,25
|
20 250
USD
|
|
2020-11-18 |
2020-11-16 |
VP
Vente planifiée
|
Brockstedt Dirk G.
Chief Scientific Officer
Dirigeant
|
9 877
-49.1%
17,01
168 008
USD
|
9 877
-49.1%
|
17,01
|
168 008
USD
|
|
2020-11-03 |
2020-11-02 |
VP
Vente planifiée
|
HO WILLIAM
Chief Medical Officer
Dirigeant
|
1 000
-1.5%
28,06
28 060
USD
|
1 000
-1.5%
|
28,06
|
28 060
USD
|
|
2020-11-03 |
2020-11-02 |
VP
Vente planifiée
|
Lam Karen C
VP, Finance and Controller
Dirigeant
|
2 022
-13.7%
28,14
56 899
USD
|
2 022
-13.7%
|
28,14
|
56 899
USD
|
|
2020-11-03 |
2020-11-02 |
VP
Vente planifiée
|
Brockstedt Dirk G.
Chief Scientific Officer
Dirigeant
|
1 910
-15.7%
28,06
53 595
USD
|
1 910
-15.7%
|
28,06
|
53 595
USD
|
|
2020-10-16 |
2020-10-15 |
VP
Vente planifiée
|
HO WILLIAM
Chief Medical Officer
Dirigeant
|
1 000
-1.5%
35,76
35 760
USD
|
1 000
-1.5%
|
35,76
|
35 760
USD
|
|
2020-10-13 |
2020-10-12 |
VP
Vente planifiée
|
Wong Brian Russell
President and CEO
Administrateur exécutif
|
20 000
-5.6%
40,05
801 040
USD
|
20 000
-5.6%
|
40,05
|
801 040
USD
|
|
2020-10-13 |
2020-10-12 |
VP
Vente planifiée
|
HO WILLIAM
Chief Medical Officer
Dirigeant
|
2 000
-2.9%
40,20
80 400
USD
|
2 000
-2.9%
|
40,20
|
80 400
USD
|
|
2020-10-02 |
2020-10-01 |
VP
Vente planifiée
|
HO WILLIAM
Chief Medical Officer
Dirigeant
|
1 000
-1.4%
31,18
31 180
USD
|
1 000
-1.4%
|
31,18
|
31 180
USD
|
|
2020-09-29 |
2020-09-28 |
A
Achat
|
Robbins Wendye
Administrateur non-exécutif
|
200
+3.1%
28,55
5 710
USD
|
200
+3.1%
|
28,55
|
5 710
USD
|
|
2020-09-29 |
2020-09-28 |
A
Achat
|
Robbins Wendye
Administrateur non-exécutif
|
300
+5.0%
28,80
8 640
USD
|
300
+5.0%
|
28,80
|
8 640
USD
|
|
2020-09-24 |
2020-09-24 |
A
Achat
|
Robbins Wendye
Administrateur non-exécutif
|
200
+3.4%
28,00
5 600
USD
|
200
+3.4%
|
28,00
|
5 600
USD
|
|
2020-09-24 |
2020-09-23 |
A
Achat
|
Robbins Wendye
Administrateur non-exécutif
|
100
+1.7%
29,50
2 950
USD
|
100
+1.7%
|
29,50
|
2 950
USD
|
|
2020-09-24 |
2020-09-23 |
A
Achat
|
Robbins Wendye
Administrateur non-exécutif
|
300
+5.5%
29,10
8 730
USD
|
300
+5.5%
|
29,10
|
8 730
USD
|
|
2020-09-23 |
2020-09-23 |
A
Achat
|
Wong Brian Russell
President and CEO
Administrateur exécutif
|
2 000
+0.6%
30,06
60 120
USD
|
2 000
+0.6%
|
30,06
|
60 120
USD
|
|
2020-09-23 |
2020-09-22 |
V
Vente
|
COLUMN GROUP II, LP
General Partner
Large shareholder
|
608 000
-13.7%
30,85
18 756 800
USD
|
608 000
-13.7%
|
30,85
|
18 756 800
USD
|
|
2020-09-22 |
2020-09-22 |
V
Vente
|
Svennilson Peter
Administrateur non-exécutif
Large shareholder
|
608 000
-13.7%
30,85
18 756 800
USD
|
608 000
-13.7%
|
30,85
|
18 756 800
USD
|
|
2020-09-15 |
2020-09-15 |
VP
Vente planifiée
|
HO WILLIAM
Chief Medical Officer
Dirigeant
|
1 000
-1.5%
36,14
36 140
USD
|
1 000
-1.5%
|
36,14
|
36 140
USD
|
|
2020-09-02 |
2020-09-01 |
VP
Vente planifiée
|
HO WILLIAM
Chief Medical Officer
Dirigeant
|
1 000
-1.5%
26,24
26 240
USD
|
1 000
-1.5%
|
26,24
|
26 240
USD
|
|
2020-08-19 |
2020-08-17 |
V
Vente
|
Svennilson Peter
Administrateur non-exécutif
Large shareholder
|
538 654
-10.8%
22,75
12 254 379
USD
|
538 654
-10.8%
|
22,75
|
12 254 379
USD
|
|
2020-08-19 |
2020-08-17 |
V
Vente
|
COLUMN GROUP II, LP
General Partner
Large shareholder
|
538 654
-10.8%
22,75
12 254 379
USD
|
538 654
-10.8%
|
22,75
|
12 254 379
USD
|
|
2020-08-18 |
2020-08-17 |
VP
Vente planifiée
|
Brockstedt Dirk G.
Chief Scientific Officer
Dirigeant
|
8 375
-45.0%
24,07
201 586
USD
|
8 375
-45.0%
|
24,07
|
201 586
USD
|
|
2020-08-18 |
2020-08-17 |
VP
Vente planifiée
|
Brockstedt Dirk G.
Chief Scientific Officer
Dirigeant
|
1 502
-7.5%
23,13
34 741
USD
|
1 502
-7.5%
|
23,13
|
34 741
USD
|
|
2020-08-18 |
2020-08-17 |
VP
Vente planifiée
|
HO WILLIAM
Chief Medical Officer
Dirigeant
|
1 000
-1.4%
24,76
24 760
USD
|
1 000
-1.4%
|
24,76
|
24 760
USD
|
|
2020-08-03 |
2020-08-03 |
VP
Vente planifiée
|
HO WILLIAM
Chief Medical Officer
Dirigeant
|
1 000
-1.4%
21,54
21 540
USD
|
1 000
-1.4%
|
21,54
|
21 540
USD
|
|
2020-07-27 |
2020-07-24 |
A
Achat
|
Robbins Wendye
Administrateur non-exécutif
|
400
+7.9%
22,75
9 100
USD
|
400
+7.9%
|
22,75
|
9 100
USD
|
|
2020-07-27 |
2020-07-24 |
A
Achat
|
Robbins Wendye
Administrateur non-exécutif
|
500
+11.0%
22,25
11 125
USD
|
500
+11.0%
|
22,25
|
11 125
USD
|
|
2020-07-16 |
2020-07-15 |
VP
Vente planifiée
|
HO WILLIAM
Chief Medical Officer
Dirigeant
|
1 000
-1.4%
28,76
28 760
USD
|
1 000
-1.4%
|
28,76
|
28 760
USD
|
|
2020-07-01 |
2020-07-01 |
A
Achat
|
Robbins Wendye
Administrateur non-exécutif
|
500
+12.3%
26,30
13 150
USD
|
500
+12.3%
|
26,30
|
13 150
USD
|
|
2020-07-01 |
2020-07-01 |
A
Achat
|
Robbins Wendye
Administrateur non-exécutif
|
500
+14.1%
26,50
13 250
USD
|
500
+14.1%
|
26,50
|
13 250
USD
|
|
2020-07-01 |
2020-07-01 |
VP
Vente planifiée
|
HO WILLIAM
Chief Medical Officer
Dirigeant
|
1 000
-1.4%
28,61
28 610
USD
|
1 000
-1.4%
|
28,61
|
28 610
USD
|
|
2020-07-01 |
2020-06-29 |
A
Achat
|
Robbins Wendye
Administrateur non-exécutif
|
1 600
+82.1%
25,77
41 232
USD
|
1 600
+82.1%
|
25,77
|
41 232
USD
|
|
2020-06-26 |
2020-06-25 |
V
Vente
|
Giordano Michael F
Administrateur non-exécutif
|
19 013
-100.0%
33,37
634 464
USD
|
19 013
-100.0%
|
33,37
|
634 464
USD
|
|
2020-06-26 |
2020-06-25 |
VP
Vente planifiée
|
Lam Karen C
VP, Finance & Controller
Dirigeant
|
875
-6.4%
35,00
30 625
USD
|
875
-6.4%
|
35,00
|
30 625
USD
|
|
2020-06-18 |
2020-06-15 |
VP
Vente planifiée
|
HO WILLIAM
Chief Medical Officer
Dirigeant
|
1 000
-1.4%
20,95
20 950
USD
|
1 000
-1.4%
|
20,95
|
20 950
USD
|
|
2020-06-02 |
2020-06-01 |
VP
Vente planifiée
|
HO WILLIAM
Chief Medical Officer
Dirigeant
|
1 000
-1.3%
18,50
18 500
USD
|
1 000
-1.3%
|
18,50
|
18 500
USD
|
|
2020-05-29 |
2020-05-26 |
V
Vente
|
Topspin Fund L.P.
Large shareholder
|
2 056 666
0,00
0
USD
|
2 056 666
|
0,00
|
0
USD
|
|
2020-05-22 |
2020-05-22 |
VP
Vente planifiée
|
HO WILLIAM
Chief Medical Officer
Dirigeant
|
7 500
-9.1%
18,02
135 150
USD
|
7 500
-9.1%
|
18,02
|
135 150
USD
|
|
2020-05-18 |
2020-05-15 |
VP
Vente planifiée
|
Brockstedt Dirk G.
Chief Scientific Officer
Dirigeant
|
9 877
-49.1%
15,00
148 155
USD
|
9 877
-49.1%
|
15,00
|
148 155
USD
|
|
2020-05-08 |
2020-05-07 |
VP
Vente planifiée
|
Lam Karen C
VP, Finance & Controller
Dirigeant
|
1 831
-14.5%
15,40
28 197
USD
|
1 831
-14.5%
|
15,40
|
28 197
USD
|
|
2019-11-15 |
2019-11-04 |
A
Achat
|
Topspin Fund L.P.
Large shareholder
|
415 000
+19.2%
12,00
4 980 000
USD
|
415 000
+19.2%
|
12,00
|
4 980 000
USD
|
|
2019-11-04 |
2019-11-04 |
A
Achat
|
RIEFLIN WILLIAM JL
Administrateur non-exécutif
|
8 000
+inf%
12,00
96 000
USD
|
8 000
+inf%
|
12,00
|
96 000
USD
|
|
2019-11-04 |
2019-11-04 |
A
Achat
|
Robbins Wendye
Administrateur non-exécutif
|
1 600
+inf%
12,00
19 200
USD
|
1 600
+inf%
|
12,00
|
19 200
USD
|
|
2019-11-04 |
2019-11-04 |
A
Achat
|
GOEDDEL DAVID V
Administrateur non-exécutif
Large shareholder
|
625 000
+14.3%
12,00
7 500 000
USD
|
625 000
+14.3%
|
12,00
|
7 500 000
USD
|
|
2019-11-04 |
2019-11-04 |
A
Achat
|
COLUMN GROUP II, LP
General Partner
Large shareholder
|
625 000
+14.3%
12,00
7 500 000
USD
|
625 000
+14.3%
|
12,00
|
7 500 000
USD
|
|
2019-11-04 |
2019-11-04 |
A
Achat
|
Wong Brian Russell
President and CEO
Administrateur exécutif
|
25 000
+25.0%
12,00
300 000
USD
|
25 000
+25.0%
|
12,00
|
300 000
USD
|
|